141 related articles for article (PubMed ID: 3497742)
1. Spontaneous production of B cell growth factors by SLE lymphocytes.
Pelton BK; Denman AM
Clin Exp Immunol; 1987 Jan; 67(1):159-66. PubMed ID: 3497742
[TBL] [Abstract][Full Text] [Related]
2. Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus.
Martinez-Cordero E; Alcocer-Varela J; Alarcon-Segovia D
Clin Exp Immunol; 1986 Sep; 65(3):598-604. PubMed ID: 3490941
[TBL] [Abstract][Full Text] [Related]
3. [Spontaneous production of interleukin-1 and B cell stimulating factors by B cells from patients with systemic lupus erythematosus].
Hirose T
Ryumachi; 1989 Aug; 29(4):277-83. PubMed ID: 2617369
[TBL] [Abstract][Full Text] [Related]
4. B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease.
Kallenberg CG; van Dissel-Emiliani F; Huitema MG; Limburg PC; The TH
J Clin Lab Immunol; 1988 Jun; 26(2):55-61. PubMed ID: 3264025
[TBL] [Abstract][Full Text] [Related]
5. Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kDa B cell growth factor, interleukin 4 and transforming growth factor-beta.
Flescher E; Fossum D; Ballester A; Maizel A; Sharma S; Talal N
Eur J Immunol; 1990 Nov; 20(11):2425-30. PubMed ID: 2253682
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
7. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
[TBL] [Abstract][Full Text] [Related]
8. B cell hyperactivity in systemic lupus erythematosus: selectively enhanced responsiveness to a high molecular weight B cell growth factor.
Delfraissy JF; Wallon C; Vazquez A; Dugas B; Dormont J; Galanaud P
Eur J Immunol; 1986 Oct; 16(10):1251-6. PubMed ID: 3095124
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
Clough JD; Krakauer RA; Frank SA; Calabrese LH
Clin Exp Immunol; 1980 Oct; 42(1):27-32. PubMed ID: 6450653
[TBL] [Abstract][Full Text] [Related]
10. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
11. Production of B cell growth factor by normal human B cells.
Jurgensen CH; Ambrus JL; Fauci AS
J Immunol; 1986 Jun; 136(12):4542-7. PubMed ID: 3519772
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human B cell proliferation by prostaglandin E2.
Thompson PA; Jelinek DF; Lipsky PE
J Immunol; 1984 Nov; 133(5):2446-53. PubMed ID: 6332851
[TBL] [Abstract][Full Text] [Related]
13. Human cell lines secreting lymphokines. II. BCGF production by a T hybridoma and B cell lines.
Gozes Y; Epstein N; Halmann M; Bino T; Rosenberg H; Kobiler D
Dev Biol Stand; 1987; 66():447-55. PubMed ID: 3495463
[TBL] [Abstract][Full Text] [Related]
14. Effect of interferon-gamma on B lymphocytes of patients with systemic lupus erythematosus.
Funauchi M; Sugishima H; Minoda M; Horiuchi A
J Rheumatol; 1991 Mar; 18(3):368-72. PubMed ID: 1906936
[TBL] [Abstract][Full Text] [Related]
15. B cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes.
Muraguchi A; Nishimoto H; Kawamura N; Hori A; Kishimoto T
J Immunol; 1986 Jul; 137(1):179-86. PubMed ID: 3486912
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a B cell activation factor (BCAF) produced by a human T cell line.
Bowen DL; Ambrus JL; Fauci AS
J Immunol; 1986 Mar; 136(6):2158-63. PubMed ID: 3485143
[TBL] [Abstract][Full Text] [Related]
17. Abnormal production of and response to B-cell growth factor and B-cell differentiation factor in patients with systemic lupus erythematosus.
Hirose T; Hara M; Kitani A; Hirose W; Norioka K; Kawagoe M; Nakamura H
Scand J Immunol; 1985 Feb; 21(2):141-50. PubMed ID: 3871963
[TBL] [Abstract][Full Text] [Related]
18. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
19. Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).
Procopio AD; Allavena P; Ortaldo JR
J Immunol; 1985 Nov; 135(5):3264-71. PubMed ID: 3876382
[TBL] [Abstract][Full Text] [Related]
20. B cell differentiation factor production in systemic lupus erythematosus.
Warrington RJ
J Rheumatol; 1988 Jan; 15(1):54-8. PubMed ID: 3258385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
